Skip to content

SCHEDULE 13DAccepted Apr 23, 8:01 PM ET

Kailera Therapeutics, Inc. SCHEDULE 13D

BCLS Fund IV Investments, L.P.

Accepted (ET)

8:01 PM

Apr 23, 2026

Filed

Apr 23, 2026

Documents

2

Size

204.0 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.